{"id":"W2591049751","doi":"10.1200/jco.2013.31.4_suppl.448","title":"Bevacizumab (Bev) with or without erlotinib as maintenance therapy, in patients (pts) with metastatic colorectal cancer (mCRC): Exploratory analysis according to KRAS status in the gercor DREAM phase III trial.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Bevacizumab; Erlotinib; KRAS; Internal medicine; Population; FOLFOX; Oncology; Colorectal cancer; FOLFIRI; Gastroenterology; Cancer; Chemotherapy; Oxaliplatin; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001514307,0.0006465258,0.001412842,0.0001967411,0.0001299613,0.0007013385,0.0004574239,0.0005921868,0.001463944],"category_scores_gemma":[0.001081807,0.0003053207,0.001221632,0.0002889487,0.0004288044,0.0005064049,0.0003727388,0.001173814,0.0002680621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006279575,"about_ca_system_score_gemma":0.0006923441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007321122,"about_ca_topic_score_gemma":0.002946653,"domain_scores_codex":[0.9994127,0.0003767135,0.00002823546,0.00007335597,0.00004145807,0.00006756161],"domain_scores_gemma":[0.9995671,0.0001096456,0.0001154333,0.00003252784,0.00001913871,0.0001560964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9329559,0.003418117,0.009390225,0.0005366023,0.002111498,0.00005087585,0.0000614617,0.001216681,0.005593343,0.0001431149,0.0008728653,0.0436494],"study_design_scores_gemma":[0.7270256,0.2241465,0.03856674,0.0001032871,0.00282136,0.0002680797,0.0000659142,0.002563619,0.001680628,0.0004637144,0.002262498,0.00003192322],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947829,0.00338595,0.0002247197,0.0002238312,0.00004420122,0.0003227848,0.0003513282,0.00002733253,0.0006369906],"genre_scores_gemma":[0.9964959,0.001117175,0.0005005029,0.0002531606,0.00005649004,0.0002968904,0.0006359419,0.000006086859,0.0006377654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001514307,"threshold_uncertainty_score":0.00800848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1051107122822753,"score_gpt":0.4617355854462316,"score_spread":0.3566248731639562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}